Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve Replacement: Insights From the NCDR STS/ACC TVT Registry

IMPORTANCE: Transcatheter aortic valve replacement (TAVR) was approved by the US Food and Drug Administration for severe aortic stenosis in patients who cannot undergo surgery and for patients at high operative risk. Use of TAVR for off-label indications has not been previously reported. OBJECTIVE:...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Cardiol
Main Authors: Hira, Ravi S., Vemulapalli, Sreekanth, Li, Zhuokai, McCabe, James M., Rumsfeld, John S., Kapadia, Samir R., Alam, Mahboob, Jneid, Hani, Don, Creighton, Reisman, Mark, Virani, Salim S., Kleiman, Neal S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2017
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5710589/
https://ncbi.nlm.nih.gov/pubmed/28636718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2017.1685
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados